Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
06/2012
06/07/2012WO2012074773A1 Personalized drug treatment methods
06/07/2012WO2012074244A2 Injectable liquid composition or injectable dried powder containing revaprazan or its salt
06/07/2012WO2012074243A2 Injectable liquid composition containing revaprazan or its salt
06/07/2012WO2012074110A1 Orally disintegrating tablet
06/07/2012WO2012074042A1 Hydroxyalkyl cellulose
06/07/2012WO2012073856A1 Oil-in-water emulsion composition containing difluprednate and tobramycin
06/07/2012WO2012073601A1 Inhibitor of attachment of periodontal-disease-inducing bacterium onto surfaces of teeth, oral biofilm formation inhibitor, and composition for oral applications
06/07/2012WO2012073245A1 Conjugates of a phospholipid and a drug for the treatment of inflammatory bowel disease
06/07/2012WO2012073125A1 Tsh-conjugated nanocarrier for the treatment of thyroid cancer
06/07/2012WO2012072943A1 Novel cationic thickeners, free of oil and surfactants, method for preparing same, and composition containing same
06/07/2012WO2012072931A1 Novel electrolyte-resistant cationic thickeners usable over a wide ph range, method for preparing same, and composition containing same
06/07/2012WO2012072930A1 Novel cationic thickeners usable over a wide ph range, method for the preparation thereof, and composition containing same
06/07/2012WO2012072911A1 Novel polymeric thickening agent free of acrylamide fragments, method for the preparation thereof, and composition containing same
06/07/2012WO2012072014A1 Transdermal patch preventing volatilization of rasagiline
06/07/2012WO2012072006A1 Liposome lyophilized composition of water soluble drug and preparation process thereof
06/07/2012WO2012071651A1 Thixotropic compositions
06/07/2012WO2012071649A1 Covalently dimerized bivalent binding agents
06/07/2012WO2012048854A3 Formulation suitable for stabilizing proteins, which is free of mammalian excipients
06/07/2012WO2012039979A3 Rapid diffusion of large polymeric nanoparticles in the mammalian brain
06/07/2012WO2012033983A3 Candesartan pharmaceutical compositions
06/07/2012WO2012028310A3 Compositions comprising a taxane for coating medical devices
06/07/2012WO2012007776A3 Disinfectant and antiseptic formulation having reduced iodine content
06/07/2012WO2011147536A3 Topical pharmaceutical compositions comprising mometasone furoate
06/07/2012WO2011146808A3 Topical formulation for a jak inhibitor
06/07/2012WO2011117333A3 Reverse micelle microemulsion comprising metal ions and use thereof
06/07/2012WO2011073234A9 Dry growth hormone composition transiently linked to a polymer carrier
06/07/2012US20120142896 Modified human interferon polypeptides and their uses
06/07/2012US20120142787 Aldehyde-functionalized polysaccharides
06/07/2012US20120142779 Stable injectable compositions
06/07/2012US20120142774 Emulsifying preparation
06/07/2012US20120142737 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
06/07/2012US20120142652 Compositions and methods for localized therapy of the eye
06/07/2012US20120142651 Method of treatment of allergic rhinitis
06/07/2012US20120142614 Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis
06/07/2012US20120142592 Nasal calcitonin formulations containing chlorobutanol
06/07/2012US20120142581 Polymer Formulations for Delivery of Bioactive Materials
06/07/2012US20120141609 Melt-Blended Protein Composition
06/07/2012US20120141590 Technology for the Preparation of Microparticles
06/07/2012US20120141582 Thixotropic Oil Based Vehicle for Pharmaceutical Compositions
06/07/2012US20120141577 Linear expression cassette vaccines
06/07/2012US20120141572 Surface Coating for Biomedical Implants and Electrodes
06/07/2012US20120141558 Alginate-based nanofibers and related scaffolds
06/07/2012US20120141551 Aptamer bioconjugate drug delivery device
06/07/2012US20120141511 Clostridial toxin derivatives able to modify peripheral sensory afferent functions
06/07/2012US20120141510 Monomethylvaline compounds capable of conjugation to ligands
06/07/2012US20120141509 Monomethylvaline compounds capable of conjugation to ligands
06/07/2012US20120141508 Monomethylvaline compounds capable of conjugation to ligands
06/07/2012US20120141452 Targeted Therapeutic Proteins
06/07/2012US20120141449 Albumin Fusion Proteins
06/07/2012US20120141416 Multimeric peptide conjugates and uses thereof
06/07/2012US20120141415 Albumin Fusion Proteins
06/07/2012US20120141379 Microspheres for active embolization
06/07/2012CA2819633A1 Pharmaceutical cream compositions and methods of use
06/07/2012CA2819512A1 Novel topical composition of sarracenia purpurea (pitcher plant)
06/07/2012CA2819460A1 Orally disintegrating tablet
06/07/2012CA2819240A1 Aptamer bioconjugate drug delivery device
06/07/2012CA2819187A1 Covalently dimerized bivalent binding agents
06/07/2012CA2817417A1 Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate
06/07/2012CA2813088A1 Thixotropic compositions
06/07/2012CA2812063A1 Shear controlled release for stenotic lesions and thrombolytic therapies
06/06/2012EP2460853A1 Water-soluble polymer composition, composition for forming plaster layer of skin patch, and skin patch
06/06/2012EP2460813A1 A beta immunogenic peptide carrier conjugates and methods of producing same
06/06/2012EP2460541A1 Kidney imaging agent comprising genetically modified gelatin
06/06/2012EP2460540A1 Kidney-targeting drug delivery agent comprising genetically modified gelatin
06/06/2012EP2460539A1 Nanosphere or microsphere drug carrier, preparation method, composition and use thereof
06/06/2012EP2460524A1 Medicinal composition for iontophoresis
06/06/2012EP2460523A1 Tablet
06/06/2012EP2460514A1 Topical pharmaceutical gel compositions of flurbiprofen, glucosamine and chondroitin
06/06/2012EP2460513A1 A method for producing adapalene gels
06/06/2012EP2460415A1 Coated preparation
06/06/2012EP2460013A1 Folate-targeted diagnostics and treatment
06/06/2012EP2459724A2 Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
06/06/2012EP2459708A1 H. pylori lipopolysaccharide outer core epitope
06/06/2012EP2459234A2 Manufacture, transport and delivery of material containing highly polarized nuclei
06/06/2012EP2459229A1 Use of constrained dipeptide and tripeptide mimic oligomers as vectorization agents
06/06/2012EP2459228A1 Prodrugs comprising an insulin linker conjugate
06/06/2012EP2459227A1 Prodrugs containing an aromatic amine connected by an amido bond to a linker
06/06/2012EP2459226A2 Glycopolysialylation of non-blood coagulation proteins
06/06/2012EP2459225A1 Carrier linked pramipexole prodrugs
06/06/2012EP2459224A2 Blood coagulation protein conjugates
06/06/2012EP2459223A2 Novel polymers
06/06/2012EP2459222A1 Sticky soft gel for treating poultry
06/06/2012EP2459221A2 Pharmaceutical formulation
06/06/2012EP2459220A1 Biodegradable polyethylene glycol based water-insoluble hydrogels
06/06/2012EP2459219A1 Aqueous carbonated medium containing an amino(meth)acrylate polymer or copolymer
06/06/2012EP2459218A1 Solutions comprising polyethylene glycol and electrolytes
06/06/2012EP2459171A1 Long acting insulin composition
06/06/2012EP2459170A2 A stable composition of ready-to-use gemcitabine injection
06/06/2012EP2459169A1 Bladder instillation compositions for treating bladder cancer
06/06/2012EP2459167A2 Subcutaneous anti-her2 antibody formulation
06/06/2012EP2458990A1 Methods for producing high concentration lyophilized pharmaceutical formulations
06/06/2012EP2196475B1 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION
06/06/2012EP2061814B1 Antibodies and immunoconjugates and uses therefor
06/06/2012EP2032172B1 Leptomycin derivatives
06/06/2012EP2004693B1 Compositions and methods of use for antibodies of c-met
06/06/2012EP1931310B1 Monophasic film-forming composition for topical administration
06/06/2012EP1667708B1 POLYETHYLENE GLYCOL CONJUGATES OF INTERFERON-BETA-1b WITH ENHANCED IN VITRO BIOLOGICAL POTENCY
06/06/2012EP1593127B1 Radiation protection by gamma-tocotrienol, alpha-tocopherol succinate or gamma-tocopherol succinate
06/06/2012EP1477164B1 Percutaneous absorption type plaster
06/06/2012EP1463558B1 Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
1 ... 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 ... 1712